Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania

OBJECTIVES: To investigate the timing, incidence, clinical presentation, pharmacokinetics and pharmacogenetic predictors for antiretroviral and anti-tuberculosis drug induced liver injury (DILI) in HIV patients with or without TB co-infection. METHODS AND FINDINGS: A total of 473 treatment naïve HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugusi, Sabina, Ngaimisi, Eliford, Janabi, Mohamed, Minzi, Omary, Bakari, Muhammad, Riedel, Klaus-Dieter, Burhenne, Juergen, Lindquist, Lars, Mugusi, Ferdinand, Sandstrom, Eric, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394799/
https://www.ncbi.nlm.nih.gov/pubmed/22808112
http://dx.doi.org/10.1371/journal.pone.0040180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394799/
https://www.ncbi.nlm.nih.gov/pubmed/22808112
http://dx.doi.org/10.1371/journal.pone.0040180

Ejemplares similares